Showing results (71-80 of 412) with videos related to
Sort By:
Pageof 42
Thescientificworldjournal|March 29, 2011
Plasmablastic lymphoma: a systematic reviewJorge J Castillo, John L ReaganAmerican Journal of Hematology|February 7, 2012
Rituximab in combination with chemotherapy versus chemotherapy alone in HIV-associated non-Hodgkin lymphoma: a pooled analysis of 15 prospective studiesJorge J Castillo, Ignacio A EcheniqueCancer|August 16, 2012
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results databaseAdam J Olszewski, Jorge J CastilloAIDS (London, England)|January 6, 2016
Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapyAdam J Olszewski, Jorge J CastilloLeukemia & Lymphoma|August 23, 2016
Secondary malignancies in patients with multiple myeloma, Waldenström macroglobulinemia and monoclonal gammopathy of undetermined significanceJorge J Castillo, Morie A GertzHematology/Oncology Clinics of North America|April 3, 2012
Why is my patient neutropenic?John L Reagan, Jorge J CastilloFuture Oncology (London, England)|June 21, 2014
Ofatumumab as front-line therapy in untreated chronic lymphocytic leukemiaJohn L Reagan, Jorge J CastilloExpert Review of Anticancer Therapy|February 24, 2011
Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemiaJohn L Reagan, Jorge J CastilloBlood|February 21, 2014
Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemiaSteven P Treon, Yang Cao, Lian Xu, et al.Seminars in Oncology|April 30, 2003
Novel biologically based therapies for Waldenstrom's macroglobulinemiaConstantine S Mitsiades, Nicholas Mitsiades, Paul G Richardson, et al.Pageof 42